Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAMP3 | O60896 | 9/20 | 0.62 |
| ▸ | CALCR | P30988 | 9/20 | 0.62 |
| ▸ | GLP1R | P43220 | 3/20 | 0.51 |
| ▸ | GCGR | P47871 | 3/20 | 0.51 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.51 |
| ▸ | MC4R | P32245 | 1/20 | 0.50 |
| ▸ | MC5R | P33032 | 1/20 | 0.50 |
| ▸ | MC3R | P41968 | 1/20 | 0.50 |
| ▸ | MC1R | Q01726 | 1/20 | 0.50 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.50 |
| ▸ | PRLHR | P49683 | 2/20 | 0.49 |
| ▸ | TFPI | P10646 | 1/20 | 0.49 |
| ▸ | APLNR | P35414 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12984102 | 0.97 | RAMP3 (0.66) | RAMP3CALCRGLP1RGCGRIL23R | |
| SCHEMBL12984646 | 0.85 | RAMP3 (0.63) | RAMP3CALCRTFPIAPLNR | |
| SCHEMBL13028975 | 0.82 | RAMP3 (0.65) | RAMP3CALCRMC4RMC5RMC3R | |
| SCHEMBL31332016 | 0.79 | MC4R (0.71) | GLP1RMC4RMC5RMC3RMC1R | |
| SCHEMBL22423719 | 0.78 | RAMP3 (0.56) | RAMP3CALCRGLP1RGCGRIL23R | |
| SCHEMBL14096140 | 0.78 | RAMP3 (0.60) | RAMP3CALCRMC4RMC5RMC3R | |
| Angiotensin Amide SCHEMBL4448793 | 0.77 | AGTR2 (0.63) | RAMP3CALCRTFPI | |
| SCHEMBL10065713 | 0.76 | RAMP3 (0.61) | RAMP3CALCRTFPI | |
| SCHEMBL30439961 | 0.76 | C5AR1 (0.55) | CALCRGLP1RGCGRMC4RAPLNR | |
| SCHEMBL10065712 | 0.76 | PLG (0.47) | IL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100316563-A1 | Method For The Preparation Of New Oligoclonal Antibodies | BRACCO IMAGING S.P.A. (IT) | 2010-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100316563-A1 | Method For The Preparation Of New Oligoclonal Antibodies | APOB, APOL1, FCGR3B | RAMP3 3589/4885CALCR 1054/4885GLP1R 4785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.